Matthew Flick: New Evidence on SARS-CoV-2 Spike Protein and Clot Formation
Matthew Flick, Professor at University of North Carolina at Chapel Hill, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”I’m excited to report that our latest publication is now available online in Blood Advances – Blood Journals Portfolio.
Here we provide data supporting the idea that the SARS-CoV-2 spike protein conditionally binds fibrin(ogen), but we refute the concept that it influences plasma clot fibrin formation, structure, or lysis.
Outstanding work by lead author Kadri Kangro. Another amazing collaboration with my colleague Alisa Wolberg and her team, namely Samer Issa.”
Title: SARS-CoV-2 spike protein can bind fibrin(ogen), but does not alter plasma fibrin formation, clot structure, or lysis
Authors: Kadri Kangro, Samer M Issa, Alisa S. Wolberg, Matthew J. Flick
Read the Full Article on Blood Advances
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 14:30Bharat Moyal: The New KDIGO 2026 Approach to Anemia in CKD
-
Aug 11, 2026, 14:16Rayan Ahmed: Master Blood Films and Pathology Online
-
Aug 11, 2026, 13:53Steven Lubega: Why Are Healthy Newborns Born Poorly Equipped To Stop Bleeding?
-
Aug 11, 2026, 13:47Why Stroke Risk Changes During Pregnancy – International Journal of Stroke
-
Aug 11, 2026, 13:43Moyahabo Julius Rampya: Shaping the Future of Stroke Care in Africa
-
Aug 11, 2026, 13:34Brett Hoover: Plaque Burden May Be Key to Predicting MACE Risk
-
Aug 11, 2026, 11:47Rucha Patil: Strengthening Evidence-Based Haemophilia Care Across India
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD